Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michael Weller
Affiliation
University Hospital and University of Zurich
ORCID
Career Start Year
1987
Papers
1139
H Index
137
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36346112
Association of antidepressant drug use with outcome of patients with glioblastoma.
Int J Cancer
2023
37488293
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Nat Med
2023
37648934
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.
J Neurooncol
2023
37609137
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability.
bioRxiv
2023
37573572
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.
Acta Neuropathol
2023
37641156
MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value.
Acta Neuropathol Commun
2023
37925634
Protocol for the expansion of mouse immune effector cells for in vitro and in vivo studies.
STAR Protoc
2023
35802605
Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.
Neuro Oncol
2023
35419607
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Neuro Oncol
2023
37059335
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.
Radiother Oncol
2023
37085569
Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours.
Nat Rev Clin Oncol
2023
37253096
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.
Neuro Oncol
2023
37343523
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas.
Cell Rep Med
2023
37277265
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).
Eur J Cancer
2023
37039262
Prognostic assessment in patients operated for brain metastasis from systemic tumors.
Cancer Med
2023
37467314
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.
Sci Transl Med
2023
37335916
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.
Neuro Oncol
2023
37368072
A T-cell antigen atlas for meningioma: novel options for immunotherapy.
Acta Neuropathol
2023
37201913
The anatomy of neuroepithelial tumours.
Brain
2023
37432631
Immunotherapy for Meningiomas.
Adv Exp Med Biol
2023
37198490
Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma.
Nature
2023
37030077
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer.
Eur J Cancer
2023
37028923
Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated disease.
J Neurol Neurosurg Psychiatry
2023
37224228
Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma.
Sci Transl Med
2023
36521332
Immunotherapy for brain metastases and primary brain tumors.
Eur J Cancer
2023
36785654
Synergies Between Venus & Exoplanetary Observations: Venus and Its Extrasolar Siblings.
Space Sci Rev
2023
36617262
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.
Neuro Oncol
2023
36843451
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
Neuro Oncol
2023
36839699
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties.
Pharmaceutics
2023
36571986
Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models.
Transl Oncol
2023
36702828
Author Correction: Federated learning enables big data for rare cancer boundary detection.
Nat Commun
2023
36632791
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.
Neuro Oncol
2023
36596831
A risk model for prediction of diagnosis of cancer after ischemic stroke.
Sci Rep
2023
36239995
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.
Clin Cancer Res
2023
36239925
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
Neuro Oncol
2023
35961053
Prognostic validation of a new classification system for extent of resection in glioblastoma: AÂ report of the RANO resect group.
Neuro Oncol
2023
35953526
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).
Neuro Oncol
2023
35917833
Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study.
Neuro Oncol
2023
34448057
Radiotherapy for glioblastoma patients with poor performance status.
J Cancer Res Clin Oncol
2022
35511454
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
Neuro Oncol
2022
35380705
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
Neuro Oncol
2022
35674736
Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group.
Neuro Oncol
2022
35545894
Venous thromboembolic events in glioblastoma patients: An epidemiological study.
Eur J Neurol
2022
35404443
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.
Neuro Oncol
2022
35796933
Mid-term treatment-related cognitive sequelae in glioma patients.
J Neurooncol
2022
35608370
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Macrocycles.
J Med Chem
2022
35762249
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.
Neuro Oncol
2022
35534067
Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings.
BMJ Open
2022
35394845
A South Pole-Aitken impact origin of the lunar compositional asymmetry.
Sci Adv
2022
35489445
Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective.
Radiother Oncol
2022
1 - 50 of 1,139
Column Actions
Search
Recommended Authors
Nancy Wang
Massachusetts General Hospital Cancer Center, Harvard Medical School
Career Start Year
2013
Number of shared co-authors
5
Farshad Nassiri
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year
2010
Number of shared co-authors
32
Adam M Sonabend
Northwestern University
Career Start Year
2005
Number of shared co-authors
19
Nancy Ann Oberheim Bush
University of California san francisco
Career Start Year
2005
Number of shared co-authors
19
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
14
Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
2002
Number of shared co-authors
14
Mariza Daras
University of California san francisco
Career Start Year
2001
Number of shared co-authors
22
Johanna Buchroithner
Johannes Kepler University
Career Start Year
2001
Number of shared co-authors
17
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year
2001
Number of shared co-authors
1
W K Alfred Yung
The University of Texas MD Anderson Cancer Center
Career Start Year
2000
Number of shared co-authors
9
Naoki Shinojima
Kumamoto University Hospital
Career Start Year
2000
Number of shared co-authors
7
Timothy E Van Meter
Virginia Commonwealthy University
Career Start Year
1998
Number of shared co-authors
57
Martin Hunn
0The Alfred Hospital
Career Start Year
1997
Number of shared co-authors
1
John A Boockvar
Lenox Hill Hospital
Career Start Year
1997
Number of shared co-authors
5
Clark C Chen
University of Minnesota
Career Start Year
1994
Number of shared co-authors
28
Thomas Str??bel
Indiana University School of Medicine
Career Start Year
1994
Number of shared co-authors
20
David M Peereboom
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Career Start Year
1993
Number of shared co-authors
28
Candelaria Gomez-Manzano
The University of Texas M.D. Anderson Cancer Center
Career Start Year
1990
Number of shared co-authors
24
G??nther Stockhammer
Medical University of Innsbruck
Career Start Year
1990
Number of shared co-authors
18
Bob S Carter
Massachusetts General Hospital and Harvard Medical School
Career Start Year
1990
Number of shared co-authors
15
Michael D Prados
University of California san francisco
Career Start Year
1987
Number of shared co-authors
66
Camilo E Fadul
University of Virginia Health System
Career Start Year
1987
Number of shared co-authors
6
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Career Start Year
1986
Number of shared co-authors
62
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Career Start Year
1984
Number of shared co-authors
31
Robert Aiken
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year
1984
Number of shared co-authors
17
Mark W Kieran
Boston Children's Hospital and Harvard Medical School
Career Start Year
1982
Number of shared co-authors
50
Takashi Shingu
The University of Texas MD Anderson Cancer Center
Career Start Year
1979
Number of shared co-authors
7
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Career Start Year
1979
Number of shared co-authors
20
Mark Rosenblum
Henry Ford Hospital
Career Start Year
1973
Number of shared co-authors
9
George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year
1970
Number of shared co-authors
41
row(s) 1 - 30 of 30
Collaborators
Guido Reifenberger
Heinrich Heine University
Co-authored papers
102
Roger Stupp
Northwestern University
Co-authored papers
83
Andreas von Deimling
Co-authored papers
81
Matthias Preusser
Medical University of Vienna
Co-authored papers
62
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Co-authored papers
54
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
41
Torsten Pietsch
Co-authored papers
41
Patrick Y Wen
Co-authored papers
40
Elisabeth J Rushing
Co-authored papers
40
Tobias Weiss
Westlake University
Co-authored papers
39
David Capper
Charite University Medicine Berlin
Co-authored papers
37
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
33
Michael A Vogelbaum
Moffit Cancer Center
Co-authored papers
27
Christel Herold-Mende
Co-authored papers
23
Kenneth Aldape
National Cancer Institute
Co-authored papers
21
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
20
Christine Marosi
Medical University of Vienna
Co-authored papers
20
Timothy F Cloughesy
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers
20
Pim J French
Erasmus MC Cancer Institute
Co-authored papers
19
Anna S Berghoff
Co-authored papers
19
Benedikt Wiestler
Technical University
Co-authored papers
18
Warren P Mason
Princess Margaret Cancer Centre
Co-authored papers
16
Peter Martus
Eberhard Karls University of Tuebingen
Co-authored papers
16
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers
14
Marcos Tatagiba
University of Tubingen
Co-authored papers
12
Andreas Unterberg
Co-authored papers
12
Karl Frei
University Hospital Zurich
Co-authored papers
12
Ahmed Idbaih
Co-authored papers
12
Minesh P Mehta
Co-authored papers
12
Christian Mawrin
Co-authored papers
12
1 - 30